[Evaluation of implantation of a cancer chemotherapeutic vascular access device: report of 91 cases].
Between April 1984 and December 1990, 91 patients with advanced cancer were implanted with vascular-access-devices 97 times. The results were as follows. When the patients were divided into two groups according to the implantation, namely the earlier (until December 1986) and later (from January 1987) periods, the earlier patency rate was higher than later due to improvement of instruments and progress in the implantation technique. There was no significant difference in the rate of patency or complications between the abdominal and femoral method, but the femoral method had some subcutaneous hematomas. The direct femoral pathway is less invasive, correct and effectively therapeutic method.
Abe
M
M
Third Dept. of Surgery, Tokyo Women's Medical College.
Nakajima
I
I
Koike
T
T
Hayashi
T
T
Honda
H
H
Fuchinoue
S
S
Teraoka
S
S
Agishi
T
T
Ota
K
K
D002408:Catheters, Indwelling; D002945:Cisplatin / Q000008:administration & dosage*; D005069:Evaluation Studies as Topic; D005263:Femoral Artery; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D015918:Infusion Pumps, Implantable / Q000592:standards; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy / Q000401:mortality; D016685:Mitomycin / Q000008:administration & dosage*; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate
D016685:Mitomycin; D002945:Cisplatin; D005472:Fluorouracil